MS

Meena Sanjiv Kapadi

Active Director Director DIN 08074814
DIN 08074814 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Mar 2018
Shareholding value •••• Premium profile

About Meena Sanjiv Kapadi

Data last updated:

Meena Sanjiv Kapadi is a Director at Flamingo Pharmaceuticals Limited (since 2022), Director at B4u Broadband (India) Private Limited (since 2022) and Director at B4u Television Network India Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Media and Publishing and Real Estate and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹1,180 Cr; the largest is Flamingo Pharmaceuticals Limited at ₹637 Cr (FY 2026). Earlier, Meena Sanjiv Kapadi was a Director at Medibios Laboratories Limited (from 2018).

DIN 08074814
Primary Designation Director
Industry Pharma
First Appointment 20 Mar 2018
Oldest Company Age 41 yrs
Largest company Flamingo Pharmaceuticals Limited · ₹637 Cr (FY 2026)
Combined revenue ₹1,180 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flamingo Pharmaceuticals Limited U51900MH1985PLC036572
Director28 Sep 20221985₹637 Cr (FY 2026)Active
Director30 Mar 20222000₹251 Cr (FY 2023)Active
B4u Television Network India Limited U92100MH1999PLC118165
Director30 Mar 20221999₹235 Cr (FY 2024)Active
Director12 Nov 20201992₹56.63 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medibios Laboratories Limited U24230MH1995PLC086180
Director20 Mar 20181995₹100 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Meena Sanjiv Kapadi

NameDINCompanyDesignation
Ashish TayalFlamingo Pharmaceuticals LimitedCfo
Ashwin Jethalal Thacker00048595Flamingo Pharmaceuticals LimitedDirector
Chhotulal Rawa Bhagwat03534822Flamingo Pharmaceuticals LimitedDirector
Parth Ashwin Thacker08202584Flamingo Pharmaceuticals LimitedDirector
Pranay Ashwin Thacker03035833Flamingo Pharmaceuticals LimitedDirector
Sukrut Jagdish ShahFlamingo Pharmaceuticals LimitedCfo
Sunil KumarFlamingo Pharmaceuticals LimitedCeo
Sunil Kumar08202567Flamingo Pharmaceuticals LimitedCeo
Harshil Pareshkumar Shah08686163B4u Broadband (India) Private Limited , B4u Television Network India LimitedCompany Secretary
Harshil Pareshkumar ShahB4u Broadband (India) Private Limited , B4u Television Network India LimitedCompany Secretary
Santosh Kumar GargB4u Broadband (India) Private Limited , B4u Television Network India LimitedCfo
Santosh Kumar Garg07262936B4u Broadband (India) Private Limited , B4u Television Network India LimitedWhole-Time Director
Vijay Jayantilal Thaker01867309B4u Broadband (India) Private Limited , B4u Television Network India LimitedDirector
Vijay Kumar Singh07603392B4u Broadband (India) Private Limited , B4u Television Network India LimitedDirector
Alok Amulya Chowdhury02133472Prime Property Development Corporation LimitedDirector
Amit Vallabhdas BhansaliPrime Property Development Corporation LimitedCfo
Kumar Girishchandra VoraPrime Property Development Corporation LimitedCeo
Manish Padamshi Soni00006485Prime Property Development Corporation LimitedWhole-Time Director
Neelam MaheshwariPrime Property Development Corporation LimitedCompany Secretary
Padamshi Ladhubhai Soni00006463Prime Property Development Corporation LimitedDirector
Vishal Padamshi Soni00006497Prime Property Development Corporation LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Prime Property Development Corporation Limited
Medibios Laboratories Limited
Flamingo Pharmaceuticals Limited
B4u Broadband (India) Private Limited
Premium access

Shareholding and investment profile for Meena Sanjiv Kapadi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meena Sanjiv Kapadi

Meena Sanjiv Kapadi currently holds 4 directorships: Flamingo Pharmaceuticals Limited (Director, since 28 Sep 2022, revenue ₹637 Cr (FY 2026)); B4u Broadband (India) Private Limited (Director, since 30 Mar 2022, revenue ₹251 Cr (FY 2023)); B4u Television Network India Limited (Director, since 30 Mar 2022, revenue ₹235 Cr (FY 2024)); Prime Property Development Corporation Limited (Director, since 12 Nov 2020, revenue ₹56.63 Cr (FY 2024)).

Meena Sanjiv Kapadi was first appointed on 20 Mar 2018 as Director at Medibios Laboratories Limited. The most recent appointment on record is 28 Sep 2022 at Flamingo Pharmaceuticals Limited.

The 4 current companies of Meena Sanjiv Kapadi that report revenue have a combined latest revenue of ₹1,180 Cr: Flamingo Pharmaceuticals Limited ₹637 Cr (FY 2026); B4u Broadband (India) Private Limited ₹251 Cr (FY 2023); B4u Television Network India Limited ₹235 Cr (FY 2024); Prime Property Development Corporation Limited ₹56.63 Cr (FY 2024).

Meena Sanjiv Kapadi held 1 earlier board appointment: Medibios Laboratories Limited (Director, from 20 Mar 2018).

The current boards of Meena Sanjiv Kapadi's companies include Ashish Tayal (Flamingo Pharmaceuticals Limited), Ashwin Jethalal Thacker (Flamingo Pharmaceuticals Limited), Chhotulal Rawa Bhagwat (Flamingo Pharmaceuticals Limited), Parth Ashwin Thacker (Flamingo Pharmaceuticals Limited), Pranay Ashwin Thacker (Flamingo Pharmaceuticals Limited), Sukrut Jagdish Shah (Flamingo Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available